Market Tracker

10/31 5:30am ET

Incyte Corp (NASDAQ:INCY)

64.18
Data as of Oct 30
 +6.31 / +10.90%
Today’s Change
35.21
Today|||52-Week Range
70.86
+26.76%
Year-to-Date

Today’s Trading

Previous close57.87
Today’s open59.02
Day’s range-- - --
Volume2,509,110
Average volume (3 months)970,229
Market cap$9.7B
Dividend yield--
Data as of 10/30/2014

Growth & Valuation

Earnings growth (last year)-64.71%
Earnings growth (this year)+36.05%
Earnings growth (next 5 years)+83.94%
Revenue growth (last year)+19.49%
P/E ratioNM
Price/Sales21.17
Price/Book--

Competitors

 Today’s
change
Today’s
% change
PCYCPharmacyclics Inc+2.51+1.90%
ENDPEndo International P...+0.64+0.97%
JAZZJazz Pharmaceuticals...+1.60+0.95%
MNKMallinckrodt Plc-0.18-0.19%
Data as of 10/30/2014

Financials

Next reporting dateFebruary 12, 2015
EPS forecast (this quarter)$0.02
Annual revenue (last year)$354.9M
Annual profit (last year)-$83.1M
Net profit margin-23.43%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Hervé Hoppenot
Chief Financial Officer &
Executive Vice President
David C. Hastings
Corporate headquarters
Wilmington, Delaware

Forecasts